Navigation Links
Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research

SAN FRANCISCO, Oct. 12 /PRNewswire/ -- Dr. Michael Merzenich, PhD - renowned neuroscientist, university professor, cochlear implant inventor, brain plasticity expert and tech entrepreneur - was formally inducted in the Institute of Medicine (IOM) today in Washington, D.C. Also a member of the National Academy of Sciences, Dr. Merzenich is one of a small group of scientists and doctors in the U.S. who have been selected for recognition by both institutions. IOM members are elected by their peers through a selective process that recognizes people who have made major contributions to the advancement of the medical sciences, health care, and public health.

"I am, of course, delighted by the generosity of my colleagues to be chosen for this honor," said Dr. Merzenich, currently co-founder and Chief Scientific Officer at Posit Science. "The discovery of the brain's ability to rewire itself has been at the core of my life's work, and I have been very fortunate to have worked with some of the brightest scientists, technologists and clinicians in the world with the mission of applying our science to improve the quality of life for others."

Dr. Merzenich is currently working with scientists and doctors at the University of California, San Francisco (UCSF) on mental health solutions, including recent promising studies on the use of brain fitness training conducted in aging, brain-injured, autistic and schizophrenic patient populations.

"Mike has been a pioneer and a leader in demonstrating that the brain function and wiring is sensitive to neural activity. His basic work has elucidated mechanisms underlying this plasticity, and his translational work has illuminated the possible ways medicine can intervene to ameliorate brain disorders," said Dr. John Rubenstein, MD, PhD, distinguished professor in Child Psychiatry at UCSF and an IOM member. "His work has revolutionized the way we view the brain's plasticity and his latest work in mental disorders illustrates his sincere dedication to alleviate human suffering."

For more than three decades, Dr. Merzenich has been a leading pioneer in brain plasticity research. In 1971, Dr. Merzenich joined the faculty of UCSF and started the Keck Center for Integrative Neurosciences. In the late 1980's, Dr. Merzenich was part of the team that invented the cochlear implant. In 1990 he became a full professor at UCSF in Neuroscience, Physiology, Biomedical Engineering and Otolaryngology. He is currently Professor Emeritus in the departments of Otolaryngology and Physiology at UCSF.

In 1996, Dr. Merzenich was the founding CEO of Scientific Learning Corporation, which markets and distributes software that applies principles of brain plasticity to assist children with language learning and reading. In 2003, Posit Science was begun by Dr. Merzenich and Jeff Zimman to take neuroscience out of the labs and put it into the hands of consumers with engaging adaptive brain fitness software.

Dr. Merzenich has published more than 200 articles, including many in leading peer-reviewed journals (such as Science and Nature), received numerous awards and prizes (including the Ipsen Prize, Zulch Prize, Thomas Alva Edison Patent Award and Purkinje Medal) and has been granted more than 50 patents for his work.

"Mike's work not only improves cognitive function across a wide array of disorders and conditions," said Zimman, Chairman of Posit Science. "Results from his studies have also been shown to significantly improve broad measures of overall health such as health-related quality-of-life and performance of everyday tasks."

Dr. Merzenich holds a BS in General Science from the University of Portland and a PhD in Physiology from Johns Hopkins University, with a Neuroscience fellowship from the University of Wisconsin at Madison. To read his blog, go to

About Posit Science

Posit Science is the leader in delivering clinically proven brain fitness software into the hands of consumers. The company combines breakthrough research and a focus on great customer experiences to create products that are engaging and help users think faster, focus better and remember more. Staff neuroscientists collaborate with more than 50 scientists from leading research institutions as well as engineers and product marketers to design, build and test our computer-based programs. Posit Science products are available online, through health, long term care and auto insurers, and from public television's "The Brain Fitness Program" documentary. For more information, visit or call 1-866-599-6463.

Posit Science is a registered trademark of Posit Science Corp. Other company and product names may be trademarks of their respective owners.

SOURCE Posit Science

SOURCE Posit Science
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Michael Troullis Appointed Chief Financial Officer of Quintiles Transnational Corp.
2. Emisphere Technologies, Inc. Appoints Michael R. Garone chief financial officer
3. Genstar Names Michael Hurt to Its Strategic Advisory Board
4. Keryx Biopharmaceuticals, Inc. Announces Appointment of Michael P. Tarnok to Board of Directors
5. MacroChem Announces Michael Zasloff, M.D., Ph.D. Joins Companys Scientific Advisory Board
6. Pharmasset Appoints Michael Rogers as Chief Development Officer
7. The Michael J. Fox Foundation Awards $2 Million to Shed Light on Role of LRRK2 and Alpha-Synuclein Genes in Parkinsons Disease
8. ImmunoVaccine Technologies appoints the Honourable Michael Kirby as Chair
9. Michael J. Simms Joins Alexza Pharmaceuticals as Senior Vice President, Operations and Manufacturing
10. Dr Michael Rosenblatt Appointed Non-Executive Director at Shire
11. Michael D. Taylor, Ph.D., Joins Cequent Pharmaceuticals Board of Directors
Post Your Comments:
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology ... drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription ... is able to cross the cell membrane and bind intracellular STAT3 and inhibit ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... program has won a US2020 STEM Mentoring Award. Representatives of the FirstHand program ... in Volunteer Experience from US2020. , US2020’s mission is to change the trajectory ...
(Date:10/10/2017)... 10, 2017 SomaGenics announced the receipt of ... develop RealSeq®-SC (Single Cell), expected to be the first ... (including microRNAs) from single cells using NGS methods. The ... to accelerate development of approaches to analyze the heterogeneity ... "New techniques for measuring levels of mRNAs in individual ...
(Date:10/9/2017)... , Oct. 9, 2017  BioTech Holdings ... mechanism by which its ProCell stem cell therapy ... limb ischemia.  The Company, demonstrated that treatment with ... of limbs saved as compared to standard bone ... molecule HGF resulted in reduction of therapeutic effect.  ...
Breaking Biology Technology:
(Date:4/11/2017)... DUBLIN , Apr. 11, 2017 Research ... Tracking Market 2017-2021" report to their offering. ... The global eye tracking market to grow at ... The report, Global Eye Tracking Market 2017-2021, has been prepared based ... report covers the market landscape and its growth prospects over the ...
(Date:4/5/2017)...  The Allen Institute for Cell Science today announces ... portal and dynamic digital window into the human cell. ... application of deep learning to create predictive models of ... a growing suite of powerful tools. The Allen Cell ... publicly available resources created and shared by the Allen ...
(Date:4/3/2017)... , April 3, 2017  Data captured ... engineering platform, detected a statistically significant association ... prior to treatment and objective response of ... potential to predict whether cancer patients will ... treatment, as well as to improve both pre-infusion ...
Breaking Biology News(10 mins):